Patent · US Active

Nucleoside prodrugs and uses thereof

US8063025B2 · kind B2 · utility

7Cited by

0References

18Claims

0Family size

Assignee

Metabasis Therapeutics, Inc. · US

Inventors

Scott Hecker · Del Mar, US
K. Raja Reddy · San Diego, US
Zhili Sun · San Diego, US
Brett C. Bookser · San Diego, US
David Bernard Smith · San Mateo, US

Key dates

Filing date	Nov 26, 2008
Grant date	Nov 22, 2011
Priority date	—
Expiry date	Jul 28, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the formula I or II wherein R1, R2, B, and V are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.